Continental Advisors’s Quest Diagnostics DGX Stock Holding History

Continental Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-15,000	Closed	-$1.67M	–	116
2017 Q2	$1.67M	Buy	+15,000	New	+$1.59M	0.38%	76

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Continental Advisors's DGX Position: Q1 2015 in Review

Continental Advisors sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 15,000 shares — an estimated $1.01M sold.

Continental Advisors first reported a position in DGX in Q2 2013 and held it in 7 quarters. The position peaked at $1.71M in Q1 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

Continental Advisors reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
Continental Advisors sold 15,000 Quest Diagnostics shares in Q1 2015, an estimated $1.01M.
Continental Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 7 quarters.
Continental Advisors's Quest Diagnostics position peaked at $1.71M in Q1 2014.
553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Continental Advisors's 13F filing for Q1 2015, filed 15 May 2015.